Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 401-408 of 408 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Cancer Distress Management Program for Liver and Biliary Cancer within a SPORE

    Rochester, MN

  2. A Study of the Bacteria Found in Cancerous and Non-cancerous Breast Tissue

    Rochester, MN

  3. Imaging of Prostatic Anatomy in Patients with Known Prostate Cancer and Those at High-Risk using Magnetic Resonance Elastography

    Rochester, MN

  4. A Bio-bank for Patients with Inflammatory Bowel Disease Associated Neoplasia

    Rochester, MN

  5. A Prospective Ocular Tumor Study

    Rochester, MN

  6. Defining the Immunologic Profile of Sentinel Lymph Nodes and Identifying the Mechanisms Responsible for Immunosuppression

    Rochester, MN, Jacksonville, FL

  7. Circulating Tumor DNA (cTDNA) Based in NGS (Next Generation Sequencing) Assays for Oncology Patients With Solid Tumors

    Rochester, MN

  8. Blood and Urine Identification of Methylated DNA Markers in Invasive Bladder Carcinoma

    Rochester, MN

.

Mayo Clinic Footer